| 摘要 |
The present invention provides uses of a recombination ganoderma lucidum immunomodulatory protein (rLZ-8) in senescence delay medicines. According to the measurement of the content of the total protein, the growth hormone, the sex hormone, the thyroid hormone and the thyroid stimulating hormone in experimental animal serum, it is found that the rLZ-8 can adjust the hormone level in the senescence process, enable the hormone level to recover to normal level, and delay the senescence process of an organism. |
